Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40 kg and no more than 16 years of age receiving Augmentin XR (amoxicillin 2000 mg/clavulanate 125 mg) orally twice daily for 10 days.

Trial Profile

An open-label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40 kg and no more than 16 years of age receiving Augmentin XR (amoxicillin 2000 mg/clavulanate 125 mg) orally twice daily for 10 days.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amoxicillin/clavulanic acid (Primary)
  • Indications Acute sinusitis; Bacterial infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline; GSK
  • Most Recent Events

    • 23 Feb 2010 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
    • 17 Aug 2007 Status changed from recruiting to completed
    • 28 Sep 2006 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top